Compare TXG & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TXG | HTFL |
|---|---|---|
| Founded | 2012 | 2007 |
| Country | United States | United States |
| Employees | N/A | 843 |
| Industry | Biotechnology: Laboratory Analytical Instruments | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.5B |
| IPO Year | 2019 | N/A |
| Metric | TXG | HTFL |
|---|---|---|
| Price | $23.76 | $29.51 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 5 |
| Target Price | $20.25 | ★ $38.20 |
| AVG Volume (30 Days) | ★ 2.5M | 1.0M |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 76.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $245,893,000.00 | N/A |
| Revenue This Year | N/A | $27.66 |
| Revenue Next Year | $7.33 | $23.55 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 68.06 | N/A |
| 52 Week Low | $8.31 | $20.13 |
| 52 Week High | $26.45 | $41.22 |
| Indicator | TXG | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 58.02 | 52.34 |
| Support Level | $19.68 | $28.60 |
| Resistance Level | $26.45 | $32.71 |
| Average True Range (ATR) | 1.38 | 1.92 |
| MACD | 0.28 | -0.25 |
| Stochastic Oscillator | 73.01 | 62.61 |
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.